SCHEMBL16637752

SCHEMBL16637752

CCCn1c(=O)c2c(C)c(OC(=O)O)sc2n(CCOC)c1=O

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 20/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16637159 0.92 ADORA2B (0.71) ADORA2B
SCHEMBL16637662 0.86 ADORA2B (0.47) ADORA2B
SCHEMBL16637750 0.86 ADORA2B (0.73) ADORA2B
SCHEMBL19611069 0.85 ADORA2B (0.78) ADORA2B
SCHEMBL16637950 0.84 ADORA2B (0.56) ADORA2B
SCHEMBL18097744 0.82 ADORA2B (0.71) ADORA2B
SCHEMBL18097608 0.81 ADORA2B (0.67) ADORA2B
SCHEMBL16637412 0.80 ADORA2B (0.66) ADORA2B
SCHEMBL16644071 0.79 ADORA2B (0.60) ADORA2B
SCHEMBL19611091 0.78 ADORA2B (0.53) ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3055313-B1 CYCLIC THIENOURACIL CARBOXAMIDE AND ITS USE Bayer Pharma AG (DE) 2017-11-22 EP disclosed
EP-3055313-A1 CYCLIC THIENOURACIL-CARBOXAMIDES AND USE THEREOF Bayer Pharma Aktiengesellschaft (DE) 2016-08-17 EP disclosed
WO-2015052065-A1 CYCLIC THIENOURACIL-CARBOXAMIDES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-04-16 WO disclosed